MedPath

Low Level Laser Therapy and Interferential Current in Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis
Registration Number
NCT02898025
Lead Sponsor
Universidade Cidade de Sao Paulo
Brief Summary

This study aims to evaluate the effectiveness of the low level laser therapy and interferential current in 168 patients with knee osteoarthritis

Detailed Description

Interventional

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
168
Inclusion Criteria
  • History of osteoarthritis of the knee characterized by pain of mild or moderate intensity
  • Radiographic evidence of grade 2 or 3 osteoarthritis based on the Kellgren and Lawrence radiographic entry criteria
  • Patients with knee osteoarthritis (s) according to the ACR criteria
  • VAS 3 to 8
  • 5 to 12 Lequesne
  • No complaint of pain in other joints of the lower limbs
  • Without neurological and cognitive disorders
  • No loss of sensation in the lower limbs
  • No surgery on the knee (s) in the last 6 months
  • Pain symptoms for at least 6 months
  • No infiltrations (s) knee (s) in the last 4 weeks
  • No use of analgesics 4 hours before treatment
Exclusion Criteria
  • Individuals younger than 18 and older than 80 years
  • Complaints from other diseases of the lower limbs, knee prosthesis and / or hip joint instabilities and / or surgery in lower limbs, heart disease, uncontrolled hypertension and diabetes, coagulation disorders in anticoagulant therapy, pregnant women, fibromyalgia and individuals who can not perform isokinetic test who have difficulty performing the TUG, and those that are experiencing abnormal sensitivity to algometry

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain intensity measured by a numeric pain scale ranging from 0 to 10.4 weeks
Pressure Pain Threshold measured by a pressure algometer. Pressure will be recorded in kPa.4 weeks
Secondary Outcome Measures
NameTimeMethod
LeQuesne QuestionnaireMeasure at baseline, 4 weeks, 3 months, 6 months
WOMAC (Western Ontario and McMaster Universities Arthritis Index)Measure at baseline, 4 weeks, 3 months, 6 months
TUG (Timed Up & Go Test)Measure at baseline, 4 weeks, 3 months, 6 months
Isokinetic Muscle AssessmentMeasure at baseline, 4 weeks, 3 months, 6 months

Trial Locations

Locations (1)

UNICID

🇧🇷

Sao Paulo, SP, Brazil

UNICID
🇧🇷Sao Paulo, SP, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.